Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sigurd Delanghe"'
Publikováno v:
Diagnostics, Vol 13, Iss 1, p 11 (2022)
Myelodysplastic syndromes (MDS) are a group of clonal myeloid disorders distinguished by dysplastic bone marrow and peripheral blood cells, ineffective hematopoiesis, and an increased risk of developing acute myeloid leukemia (AML). MDS with ring sid
Externí odkaz:
https://doaj.org/article/da882ae69120414eb0ec705a99a4a311
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM).
Detection of hemoglobin (Hb) and red blood cells in urine (hematuria) is characterized by a large number of pitfalls. Clinicians and laboratory specialists must be aware of these pitfalls since they often lead to medical overconsumption or incorrect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea8f864f9f13155017dc64cc48b0058
https://doi.org/10.1515/cclm-2023-0260
https://doi.org/10.1515/cclm-2023-0260
Publikováno v:
Diagnostics
DIAGNOSTICS
DIAGNOSTICS
Myelodysplastic syndromes (MDS) are a group of clonal myeloid disorders distinguished by dysplastic bone marrow and peripheral blood cells, ineffective hematopoiesis, and an increased risk of developing acute myeloid leukemia (AML). MDS with ring sid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fdd54ec66fe7f1619704774feb9751d
https://hdl.handle.net/10067/1934650151162165141
https://hdl.handle.net/10067/1934650151162165141
Autor:
Lore De Ryck, Sigurd Delanghe, Celine Jacobs, Sharareh Fadaei, Lieve Brochez, Michael Saerens
Publikováno v:
Acta clinica Belgica.
The introduction of BRAF/MEK inhibitors has significantly improved overall survival of patients with BRAF V600-mutant advanced or metastatic melanoma. Most patients treated with BRAF/MEK inhibitors will experience adverse events during the course of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::559b12105ae7fa1b7b8f3a751b127145
https://pubmed.ncbi.nlm.nih.gov/35996969
https://pubmed.ncbi.nlm.nih.gov/35996969
Autor:
Sigurd, Delanghe, Alena, Moerman, Anneleen, Pletinck, Eva, Schepers, Griet, Glorieux, Wim, Van Biesen, Joris R, Delanghe, Marijn M, Speeckaert
Publikováno v:
Electrophoresis. 38(17)
Protein carbamylation, a nonenzymatic posttranslational modification promoted during uremia, is linked to a poor prognosis. In the present study, carbamylation of serum albumin was assayed using the symmetry factor on a capillary electrophoresis inst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::072b2380021b476cf8326475e86cacd8
https://pubmed.ncbi.nlm.nih.gov/28556931
https://pubmed.ncbi.nlm.nih.gov/28556931